Evidence map›Paper›PMID 36002714›Full record

ArticleHepatology international2022

Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma.

Peng Wang, Abraham S Moses, Chao Li, Song Chen, Xun Qi, Ke Xu, Hai-Bo Shao, Xiang-Jun Han

Open access · hybridAbstract read
In one paragraph

Article in Hepatology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Early Hemostatic Treatment Could Improve 30-Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Peng WangDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Abraham S MosesDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Chao LiDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Song ChenDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Xun QiDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Ke XuDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Hai-Bo ShaoDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Xiang-Jun HanDepartment of Interventional Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China. xjhan@cmu.edu.cn.ORCID http://orcid.org/0000-0003-1931-9065
First Hospital of China Medical University · CNOregon State University · US

Funding

National Natural Science Foundation of China 81901816National Natural Science Foundation of China 81901846
6 · The paper itself

Abstract

aimTo investigate predictors affecting survival in patients with spontaneously ruptured hepatocellular carcinoma (srHCC).

methodsOne-hundred-and-twenty-seven patients experiencing srHCC between January 2010 and December 2020 were enrolled. The clinical features, treatments, and outcomes were reviewed. Statistics included univariate analysis, Kaplan-Meier analysis, multivariate analysis using Cox proportional hazards model and logistic regression model, and receiver operating characteristic (ROC) curve analysis.

resultsOf the 127 srHCC patients, 24, 42, and 61 patients received conservative treatment, surgical treatment, and transarterial chemoembolization/embolization (TACE/TAE) treatment at HCC rupture, respectively. The largest tumor size [hazard ratio (HR) 1.127; p < 0.001], Barcelona-Clinic Liver Cancer (BCLC) stage (HR 2.184, p = 0.023), international normalized ratio (INR; HR 3.895; p = 0.012), total bilirubin level (TBil; HR 1.014; p = 0.014), TACE after rupture (compared with conservative treatment) (HR 0.549; p = 0.029), TACE/TAE and surgery at rupture, and albumin level (HR 0.949; p = 0.017) were independent predictors affecting overall survival. A survival predictive model for HCC rupture (SPHR) using these predictors was created. ROC analysis showed that the area under the curve (AUC) of the SPHR model for 30 day survival was 0.925, and the AUCs of the model for end-stage liver disease (MELD) score and Child-Pugh score for 30 day survival were 0.767 and 0.757, respectively.

conclusionThe largest tumor size, advanced BCLC stage, higher INR and TBil, lower albumin, and conservative treatment were negative independent predictors for overall survival. The SPHR model may be more suitable than the MELD score and Child-Pugh score for predicting 30 day survival in srHCC.

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticEnd Stage Liver DiseaseLiver NeoplasmsAlbuminsHumansNeoplasm StagingPrognosisRetrospective StudiesSeverity of Illness IndexTreatment OutcomeAlbuminsChild–PughHepatocellular carcinomaMELDPredictive modelPrognosisRisk factorsRuptureSurgical treatmentSurvivalTransarterial embolization

Identifiers

PMID36002714
PMCPMC9701175
OpenAlexW4293103016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.